The μ-opioid receptor agonist remifentanil induces acute dysphoria irrespective of its analgesic properties

Journal of Psychopharmacology

Volumn 24, Issue 3, 2010, Pages 355-361

  Wagner, K J ^a   Valet, M ^a   Kochs, E F ^a   Kriner, M ^a   Tolle T R ^a   Sprenger, T ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Dysphoria; Mood; Opioids; Pain; Remifentanil; U receptor

Indexed keywords

MU OPIATE RECEPTOR AGONIST; PLACEBO; REMIFENTANIL; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ACUTE DISEASE; ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; HUMAN; LOW DRUG DOSE; MALE; MOOD DISORDER; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY STIMULATION; THERMAL STIMULATION; TREATMENT RESPONSE; AFFECT; DOSE RESPONSE; DRUG POTENTIATION;

ADULT; AFFECT; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PAIN; PIPERIDINES; RECEPTORS, OPIOID, MU;

EID: 77953047192     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108095811     Document Type: Article

References (35)

1. Apkarian, AV, Bushnell, MC, Treede, RD, Zubieta, JK (2005) Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9: 463-484.
2. Baylon, GJ, Kaplan, HL, Somer, G, Busto, UE, Sellers, EM (2000) Comparative abuse liability of intravenously administered remifentanil and fentanyl. J Clin Psychopharmacol 20: 597-606.
3. Black, ML, Hill, JL, Zacny, JP (1999) Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers. Anesthesiology 90: 718-726.
4. Bodnar, RJ, Klein, GE (2006) Endogenous opiates and behavior: 2005. Peptides 27: 3391-3478.
5. Corbett, AD, Henderson, G, McKnight, AT, Paterson, SJ (2006) 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 147(Suppl. 1): S153-S162.
6. Crozier, TA, Kietzmann, D, Dobereiner, B (2004) Mood change after anaesthesia with remifentanil or alfentanil. Eur J Anaesthesiol 21: 20-24. (Pubitemid 38029418)
7. Domino, KB, Hornbein, TF, Polissar, NL, Renner, G, Johnson, J, Alberti, S, et al. (2005) Risk factors for relapse in health care professionals with substance use disorders. JAMA 293: 1453-1460. (Pubitemid 40393289)
8. Gastpar, M, Singer, A, Zeller, K (2006) Comparative efficacy and safety of a once-daily dosage of Hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study. Pharmacopsychiatry 39: 66-75.
9. Glass, PS, Gan, TJ, Howell, S (1999) A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 89: S7-S14.
10. Gold, MI, Watkins, WD, Sung, YF, Yarmush, J, Chung, F, Uy, NT, et al. (1997) Remifentanil versus remifentanil/midazolam for ambulatory surgery during monitored anesthesia care. Anesthesiology 87: 51-57. (Pubitemid 27438622)
11. Graber, SA, Silveri, MM, Yurgelun-Todd, DA (2007) Neuropsychological consequences of opiate use. Neuropsychol Rev 17: 299-315.
12. Gupta, A, Kullander, M, Ekberg, K, Lennmarken, C (1996) Anaesthesia for day-care arthroscopy. A comparison between desflurane and isoflurane. Anaesthesia 51; 56-62.
13. Heimann, H, Bobon-Schrod, H, Schmocker, AM, Bobon, DP (1975) Self-rating of mood using a list of adjectives, Zersen's Befindlichkeits-Skala (BS). Encephale 1: 165-183.
14. Hill, JL, Zacny, JP (2000) Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. Psychopharmacology (Berl) 152: 31-39.
15. Hiller, JM, Fan, LQ (1996) Laminar distribution of the multiple opioid receptors in the human cerebral cortex. Neurochem Res 21: 1333-1345. (Pubitemid 26397063)
16. Hughes, MA, Glass, PS, Jacobs, JR (1992) Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 76: 334-341.
17. James, MK, Feldman, PL, Schuster, SV, Bilotta, JM, Brackeen, MF, Leighton, HJ (1991) Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 259: 712-718.
18. Kalman, SH, Jensen, AG, Ekberg, K, Eintrei, C (1993) Early and late recovery after major abdominal surgery. Comparison between propofol anaesthesia with and without nitrous oxide and isoflurane anaesthesia. Acta Anaesthesiol Scand 37: 730-736.
19. Kapila, A, Glass, PS, Jacobs, JR, Muir, KT, Hermann, DJ, Shiraishi, M, et al. (1995) Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83: 968-975.
20. Laird, NM, Ware, JH (1982) Random-effects models for longitudinal data. Biometrics 38: 963-974.
21. Lasagna, L, Von Felsinger, JM, Beecher, HK (1955) Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts. J Am Med Assoc 157:1006-1020.
22. Lautenbacher, S, Roscher, S, Strian, F (1995) Tonic pain evoked by pulsating heat: temporal summation mechanisms and perceptual qualities. Somatosens Mot Res 12: 59-70.
23. Lindemann, E, Felsinger, JM (1961) Drug effects and personality theory. Psychopharmacologia 2: 69-92.
24. Marshall, CA, Jones, RM, Bajorek, PK, Cashman, JN (1992) Recovery characteristics using isoflurane or propofol for maintenance of anaesthesia: a double-blind controlled trial. Anaesthesia 47: 461-466.
25. Oxorn, D, Orser, B, Ferris, LE, Harrington, E (1994) Propofol and thiopental anesthesia: a comparison of the incidence of dreams and perioperative mood alterations. Anesth Analg 79: 553-557.
26. Pfeiffer, A, Brantl, V, Herz, A, Emrich, HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233: 774-776.
27. Pollard, BJ, Bryan, A, Bennett, D, Faragher, EB, Un, EN, Keegan, M, et al. (1994) Recovery after oral surgery with halothane, enflurane, isoflurane or propofol anaesthesia. Br J Anaesth 72: 559-566. (Pubitemid 24148054)
28. von Zerssen, D, Koeller, DM, Rey, ER. (1970) A scale for the objective evaluation of the state of subjective well-being as a method for longitudinal studies. Arzneimittelforschung 20: 915-918.
29. Wagner, KJ, Sprenger, T, Kochs, EF, Tolle, TR, Valet, M, Willoch, F (2007) Imaging human cerebral pain modulation by dosedependent opioid analgesia: a positron emission tomography activation study using remifentanil. Anesthesiology 106: 548-556. (Pubitemid 46662221)
30. Wagner, KJ, Willoch, F, Kochs, EF, Siessmeier, T, Tolle, TR, Schwaiger, M, et al. (2001) Dose-dependent regional cerebral blood flow changes during remifentanil infusion in humans: a positron emission tomography study. Anesthesiology 94: 732-739. (Pubitemid 32429740)
31. Westmoreland, CL, Hoke, JF, Sebel, PS, Hug, CC, Muir, KT (1993) Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 79: 893-903.
32. White, PF, Kehlet, H, Neal, JM, Schricker, T, Carr, DB, Carli, F (2007) The role of the anesthesiologist in fast-track surgery: from multimodal analgesia to perioperative medical care. Anesth Analg 104: 1380-1396[table].
33. Wilmore, DW, Kehlet, H (2001) Management of patients in fast track surgery. BMJ 322: 473-476.
34. Zacny, JP, Hill, JL, Black, ML, Sadeghi, P (1998) Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther 286: 1197-1207.
35. Zacny, JP, Lichtor, JL, Zaragoza, JG, de Wit, H (1992) Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology (Berl) 107: 319-326.